Cardiology journal最新文献_第10页

Serial electrocardiographic and echocardiographic assessments of cardiac amyloidosis presenting with myocardial ischemia 对出现心肌缺血的心脏淀粉样变性进行连续心电图和超声心动图评估

Cardiology journal Pub Date : 2023-12-01 DOI: 10.5603/cj.97076

Takao Konishi, Akira Hamabe

引用次数: 0

Nightmare as a trigger for stress cardiomyopathy 噩梦是应激性心肌病的诱因

Cardiology journal Pub Date : 2023-12-01 DOI: 10.5603/cj.97167

Marc Arcens, Stephane Noble

引用次数: 0

Sky is the limit for Impella-assisted percutaneous coronary intervention: Four technologies, three vessels, two bifurcations and one chronic total occlusion Impella辅助经皮冠状动脉介入治疗的天空是无限的：四种技术、三条血管、两个分叉和一个慢性全闭塞

Cardiology journal Pub Date : 2023-12-01 DOI: 10.5603/cj.96740

Aleksandra Gąsecka, Norbert Czyżak, Marcin Lampart, A. Pietrasik

引用次数: 0

Stiff wire scratching to fenestration, de-escalation, and re-entry technique (SSDR): A novel wire-based antegrade dissection/re-entry technique for coronary chronic total occlusion recanalization. 硬钢丝刮除开窗、减压和再通技术（SSDR）：一种用于冠状动脉慢性完全闭塞再通的新型钢丝顺行剥离/再通技术。

Cardiology journal Pub Date : 2023-01-01 Epub Date: 2023-09-29 DOI: 10.5603/cj.92864

Mihajlo Kovačić

引用次数: 0

The use of cardiac markers in the prediction of COVID-19. 心脏标志物在新冠肺炎预测中的应用。

Cardiology journal Pub Date : 2023-01-01 Epub Date: 2023-09-29 DOI: 10.5603/cj.96345

Mohamad Gholamhosain Moghadam, Małgorzata Cielicka, Piotr Łojko

引用次数: 0

AngioScore: An artificial intelligence tool to assess coronary artery lesions. AngioScore：一种评估冠状动脉病变的人工智能工具。

Cardiology journal Pub Date : 2023-01-01 Epub Date: 2023-10-12 DOI: 10.5603/cj.95508

Ewelina Blazejowska, Jakub Michal Zimodro, Tomasz Figatowski, Adam Brzeski, Tomasz Dziubich, Jaroslaw Parzuchowski, Aleksandra Gasecka, Radoslaw Targonski

引用次数: 0

Beyond ChatGPT: What does GPT-4 add to healthcare? The dawn of a new era. 超越ChatGPT：GPT-4为医疗保健增加了什么？一个新时代的黎明。

Cardiology journal Pub Date : 2023-01-01 Epub Date: 2023-10-13 DOI: 10.5603/cj.97515

Simona Wójcik, Anna Rulkiewicz, Piotr Pruszczyk, Wojciech Lisik, Marcin Poboży, Justyna Domienik-Karłowicz

{"title":"Beyond ChatGPT: What does GPT-4 add to healthcare? The dawn of a new era.","authors":"Simona Wójcik, Anna Rulkiewicz, Piotr Pruszczyk, Wojciech Lisik, Marcin Poboży, Justyna Domienik-Karłowicz","doi":"10.5603/cj.97515","DOIUrl":"10.5603/cj.97515","url":null,"abstract":"Over the past few years, artificial intelligence (AI) has significantly improved healthcare. Once the stuff of science fiction, AI is now widely used, even in our daily lives - often without us thinking about it. All healthcare professionals - especially executives and medical doctors - need to understand the capabilities of advanced AI tools and other breakthrough innovations. This understanding will allow them to recognize opportunities and threats emerging technologies can bring to their organizations. We hope to contribute to a meaningful public discussion about the role of this new type of AI and how our approach to healthcare and medicine can best evolve with the rapid development of this technology. Since medicine learns by example, only a few possible uses of AI in medicine are provided, which merely outline the system's capabilities. Among the examples, it is worth highlighting the roles of AI in medical notes, education, preventive programs, consultation, triage and intervention. It is believed by the authors that large language models such as chat generative pre-trained transformer (ChatGPT) are reaching a level of maturity that will soon impact clinical medicine as a whole and improve the delivery of individualized, compassionate, and scalable healthcare. It is unlikely that AI will replace physicians in the near future. The human aspects of care, including empathy, compassion, critical thinking, and complex decision-making, are invaluable in providing holistic patient care beyond diagnosis and treatment decisions. The GPT-4 has many limitations and cannot replace direct contact between an experienced physician and a patient for even the most seemingly simple consultations, not to mention the ethical and legal aspects of responsibility for diagnosis.","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713213/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41223563","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Right superior pulmonary vein parameter determined by three-dimensional transesophageal echocardiography is an independent predictor of the outcome after cryoballoon isolation of the pulmonary veins. 三维经食管超声心动图测定的右上肺静脉参数是冷冻球囊分离肺静脉后结果的独立预测指标。

Cardiology journal Pub Date : 2023-01-01 Epub Date: 2023-10-19 DOI: 10.5603/cj.95381

Laszlo Tibor Nagy, Timea Bianka Papp, Reka Urbancsek, Csaba Jenei, Zoltan Csanadi

{"title":"Right superior pulmonary vein parameter determined by three-dimensional transesophageal echocardiography is an independent predictor of the outcome after cryoballoon isolation of the pulmonary veins.","authors":"Laszlo Tibor Nagy, Timea Bianka Papp, Reka Urbancsek, Csaba Jenei, Zoltan Csanadi","doi":"10.5603/cj.95381","DOIUrl":"10.5603/cj.95381","url":null,"abstract":"Background: A direct comparison of three-dimensional transesophageal echocardiography (3DTEE) and cardiac computed tomography imaging has demonstrated good inter-technique agreement for the following pulmonary vein (PV) parameters: the ostium area of the right superior PV (RSPV) and its major (a) and minor axis (b) diameters, the left lateral ridge and the minor axis (b) diameter of the left superior PV. Herein, under investigation, was the predictive value of these parameters for arrhythmia recurrence (AR) after PV isolation with the 28 mm second generation cryoballoon (CBG2).Methods: One hundred eleven patients (67 men, mean age 58.06 ± 10.58 years) undergoing 3DTEE before PV isolation with the CBG2 for paroxysmal atrial fibrillation were followed. \"Point by point\" redo intervention was offered in case of AR and reconnected PVs were defined.Results: During a mean follow-up of 617 ± 258.86 days, 65 (58.9%) patients remained free of AR. Longer RSPV b was found to be the only significant predictor for AR (hazard ratio [HR] 1.059; 95% confidence interval [CI] 1.000-1.121; p = 0.048). RSPV b ≥ 28 mm resulted in a threefold (HR 3.010; 95% CI 1.270-7.134, p = 0.012) increase in the risk of AR. The association of RSPV b with AR was independent of the biophysical parameters of cryoapplications. In 25 \"redo\" patients, reconnections were found 1.75 times more likely in the RSPV than in the other 3 PVs altogether.Conclusions: Right superior PV b measured with 3DTEE might be a significant predictor of AR after PV isolation with the CBG2. In case of RSPV b exceeding 28 mm, alternative PV isolation techniques or use of a larger balloon might be considered.","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713212/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49686259","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Novel planned two-stent technique for bifurcation lesions: Inverted compression T-stenting. 针对分叉病变的新型计划双支架技术:倒置压缩t型支架置入。

Cardiology journal Pub Date : 2023-01-01 Epub Date: 2023-11-21 DOI: 10.5603/cj.97345

Fumiaki Nakao

引用次数: 0

STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice. 争取。意大利-波兰-西班牙-乌兹别克斯坦-越南专家论坛立场文件2023在临床实践中更好地控制经典可改变的风险因素。

Cardiology journal Pub Date : 2023-01-01 Epub Date: 2023-11-21 DOI: 10.5603/cj.96912

Krzysztof J Filipiak, Vivencio Barrios, Claudio Ferri, Khurshid Fozilov, Santiago Jesus Freire Castro, Agnieszka Kuzior, Francisco Javier Martinez-Martin, Guzal Mullabaeva, Lan Hieu Nguyen, Ulugbek Nizamov, Anna Tomaszuk-Kazberuk, Raisa Trigulova, Aleksandra Gąsecka

{"title":"STRUGGLE FOR. Italian-Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023 for better control of classical modifiable risk factors in clinical practice.","authors":"Krzysztof J Filipiak, Vivencio Barrios, Claudio Ferri, Khurshid Fozilov, Santiago Jesus Freire Castro, Agnieszka Kuzior, Francisco Javier Martinez-Martin, Guzal Mullabaeva, Lan Hieu Nguyen, Ulugbek Nizamov, Anna Tomaszuk-Kazberuk, Raisa Trigulova, Aleksandra Gąsecka","doi":"10.5603/cj.96912","DOIUrl":"10.5603/cj.96912","url":null,"abstract":"The progress in pharmacotherapy that has been made in recent years, including the introduction of very effective and safe lipid-lowering and antihypertensive drugs, has not yet translated into the expected universal control of blood pressure, lipid disorders and diabetes. In the STRUGGLE FOR Italian- -Polish-Spanish-Uzbek-Vietnamese Expert Forum Position Paper 2023, experts from five countries recounted several points about the paradigms of cardiological and cardiometabolic care for better control of classical modifiable risk factors in the year 2023. It is believed herein, that the need to intensify treatment, actively search for patients with cardiovascular risk factors, especially with arterial hypertension, hypercholesterolemia and diabetes, should go hand in hand with the implementation of the latest therapy, based on single pill combinations including proven, effective antihypertensive, lipid-lowering and antidiabetic molecules, many of which are listed in the present document. There is a need to use both new technological concepts, completely new drugs, as well as novel treatment concepts such as metabolic treatment in coronary artery disease, try to intensify the fight against smoking in every way, including the available range of drugs and procedures reducing the harm. This approach will provide substantially better control of the underlying cardiovascular risk factors in countries as varied as Italy, Poland, Spain, Uzbekistan and Vietnam.","PeriodicalId":93923,"journal":{"name":"Cardiology journal","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10713228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138178200","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0